Resultados de procura - Annette Langer‐Gould

Limitar resultados
  1. 1
    Validation of the Swedish Multiple Sclerosis Register

    Validation of the Swedish Multiple Sclerosis Register por Peter Alping, Fredrik Piehl, Annette Langer‐Gould, Thomas Frisell

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Multiple sclerosis, rituximab, and COVID‐19

    Multiple sclerosis, rituximab, and COVID‐19 por Annette Langer‐Gould, Jessica B. Smith, Bonnie H. Li

    Publicado 2021
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome

    Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome por Annette Langer‐Gould, Sonu M. Brara, Brandon Beaber, Corinna Koebnick

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Multiple Sclerosis, Rituximab, Hypogammaglobulinemia, and Risk of Infections

    Multiple Sclerosis, Rituximab, Hypogammaglobulinemia, and Risk of Infections por Annette Langer‐Gould, Bonnie H. Li, Jessica Smith, Stanley Xu

    Publicado 2024
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Pediatric Idiopathic Intracranial Hypertension and Extreme Childhood Obesity

    Pediatric Idiopathic Intracranial Hypertension and Extreme Childhood Obesity por Sonu M. Brara, Corinna Koebnick, Amy H. Porter, Annette Langer‐Gould

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility

    Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility por Kerstin Hellwig, Lie H. Chen, Frank Z Stancyzk, Annette Langer‐Gould

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis

    Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis por Jessica B. Smith, Edlin Gonzales, Bonnie H. Li, Annette Langer‐Gould

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis

    Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis por Lilyana Amezcua, Jessica B. Smith, Edlin Gonzales, Samantha Haraszti, Annette Langer‐Gould

    Publicado 2020
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab

    Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab por Annette Langer‐Gould, Scott W. Atlas, Ari Green, Andrew W. Bollen, Daniel Pelletier

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Multiple Sclerosis, Disease-Modifying Therapies, and Infections

    Multiple Sclerosis, Disease-Modifying Therapies, and Infections por Annette Langer‐Gould, Jessica B. Smith, Edlin Gonzales, Fredrik Piehl, Bonnie H. Li

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children

    Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children por Annette Langer‐Gould, J.L. Zhang, Joanie Chung, Y. Yeung, Emmanuelle Waubant, Yao Jianhua

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Racial and Ethnic Disparities in Multiple Sclerosis Prevalence

    Racial and Ethnic Disparities in Multiple Sclerosis Prevalence por Annette Langer‐Gould, Edlin Gonzales, Jessica B. Smith, Bonnie H. Li, Lorene M. Nelson

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Rituximab, MS, and pregnancy

    Rituximab, MS, and pregnancy por Jessica B. Smith, Kerstin Hellwig, Katharina Fink, Deirdre J. Lyell, Fredrik Piehl, Annette Langer‐Gould

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Environmental and genetic risk factors for MS: an integrated review

    Environmental and genetic risk factors for MS: an integrated review por Emmanuelle Waubant, Robyn Lucas, Ellen M. Mowry, Jennifer Graves, Tomas Olsson, Lars Alfredsson, Annette Langer‐Gould

    Publicado 2019
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  15. 15
    Breastfeeding, ovulatory years, and risk of multiple sclerosis

    Breastfeeding, ovulatory years, and risk of multiple sclerosis por Annette Langer‐Gould, Jessica B. Smith, Kerstin Hellwig, Edlin Gonzales, Samantha Haraszti, Corinna Koebnick, Anny H. Xiang

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Safety of potential breast milk exposure to IFN-β or glatiramer acetate

    Safety of potential breast milk exposure to IFN-β or glatiramer acetate por Andrea I. Ciplea, Annette Langer‐Gould, Anna Ståhl, Sandra Thiel, Annette Queißer-Wahrendorf, Ralf Gold, Kerstin Hellwig

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Association between maternal inflammatory bowel disease and adverse perinatal outcomes

    Association between maternal inflammatory bowel disease and adverse perinatal outcomes por Darios Getahun, Michael J. Fassett, George F. Longstreth, Corinna Koebnick, Annette Langer‐Gould, Daniel Strickland, Steven J. Jacobsen

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder

    Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder por Andrea I. Ciplea, Annette Langer‐Gould, Annick de Vries, Tiny Schaap, Sandra Thiel, Marius Ringelstein, Ralf Gold, Kerstin Hellwig

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses

    Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses por Kerstin Hellwig, Milena Rockhoff, Sandra Herbstritt, Nadja Borisow, Aiden Haghikia, Birte Elias-Hamp, Sylvia Menck, Ralf Gold, Annette Langer‐Gould

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy

    Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy por Kerstin Hellwig, Marianne Tokic, Sandra Thiel, Nina Esters, Charlotte Spicher, Nina Timmesfeld, Andrea I. Ciplea, Ralf Gold, Annette Langer‐Gould

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: